France’s Lesaffre Group entered the human health market in 2007 with the establishment of Lesaffre Human Care, which quickly became a world expert in fermentation dedicated to the human nutrition and health market. During the following decade, the Lesaffre Group integrated several leaders in human health, including Gnosis Advanced Biotech, Omniabios, and invested in Envera and Intralytix.

More recently, the newly created Gnosis by Lesaffre business unit unveiled its new, fully integrated brand and business strategy to help make this vision a reality.

Gnosis by Lesaffre harnesses the power of microorganisms and biotransformation processes like fermentation to cultivate nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and wellbeing. The business unit collaborates with dietary supplement, functional food and beverage, and pharmaceutical brands to develop game-changing products for their customers.

“The term ‘biotransformation’ may be unfamiliar to some in the industry, but it refers to fermentation and other natural processing methods that involve transforming compounds within a living system,” says General Manager Marc Philouze. “It describes exactly what we do. We use living microorganisms to transform compounds into usable nutritional actives.”

He adds, “We’ve brought together leaders in human health and nutrition from around the world to form the now fully integrated Gnosis by Lesaffre. We’re committed to always exploring the potential of biotransformation, which we believe is limitless. It’s truly an untapped, transformative resource that will help us develop natural, sustainable, and efficacious solutions for our partners.”

The business unit draws on its focused research and applications capabilities, rigorous quality and regulatory compliance, and extensive clinical validation procedures to develop effective solutions for its key markets: Wellness & Immune Health, Digestion & Gut Health, Mobility & Joint Health, Reproduction & Women’s Health, and Mood & Cognitive Health.

“In the past, we have focused solely on building awareness for our renowned ingredients, such as Quatrefolic® and Lynside® nutritional yeasts,” notes Global Marketing Director Philippe Caillat. “At the same time, we have been building our expertise and market leadership for our key market segments, so we are proud to bring those to the forefront of our brand strategy.”

Within its market segments, Gnosis by Lesaffre has developed a portfolio of solutions that improve health and wellbeing throughout the entire body:

Wellness & Immune Health: Immunity, Daily Nutrition, Cardiovascular Health, Beauty, and General Wellbeing

Digestion & Gut Health: Microbiome Balance, Digestive Comfort, Liver Health Support

Mobility & Joint Health: Bone Health, Joint Health, Muscle Health, and Sports Nutrition

Reproduction & Women’s Health: Vaginal Care, Urinary Health, Fertility, Pregnancy, and Menopause

Mood & Cognitive Health: Mood Health, Cognition, and Stress & Anxiety

Gnosis by Lesaffre has prepared a webinar entitled “Exploring Life to Improve Living” where food scientists may learn how microbial biotransformation can help brands develop products that help their customers, and ultimately consumers, thrive.

View the webinar.